Follow The Filings

RS Reliance

Reliance earnings company data as of 4:54 AM ET 9/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 28 Oct EPS 6.55 — —
Rev — — —

Insider trades

Open-market buys and sales by RS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RS insider trades
  • None no insider bought on the open market
  • $16M sold by 5 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Karen Winifred Colonias Director
    Sale
    $602K 1,542 shares at $390.13 17% of stake
    Traded Aug 26 Filed Aug 27
  2. Arthur Ajemyan CFO
    Sale
    $902K 2,200 shares at $410.11 13% of stake
    Traded Jul 31 Filed Aug 4
  3. William A Smith II SVP, General Counsel, Corp Sec
    Sale
    $975K 2,353 shares at $414.21 11% of stake
    Traded Jul 28 Filed Jul 29
  4. Arthur Ajemyan CFO
    Sale
    $1.3M 3,500 shares at $358.12 17% of stake
    Traded Apr 27 Filed Apr 28
  5. William A Smith II SVP, General Counsel, Corp Sec
    Sale
    $2M 6,615 shares at $298.61 23% of stake
    Traded Mar 9 Filed Mar 10
  6. Stephen Paul Koch COO
    Sale
    $7.7M 24,060 shares at $321.62 63% of stake
    Traded Feb 23 Filed Feb 25
  7. Karla R Lewis CEO
    Sale
    $1.6M 5,809 shares at $283.50 6.4% of stake
    Traded Dec 1, 2025 Filed Dec 2, 2025
  8. Stephen Paul Koch COO
    Sale
    $869K 3,066 shares at $283.56 18% of stake
    Traded Dec 1, 2025 Filed Dec 2, 2025

Also filed in the last 12 months, not counted as buying or selling: 16 stock grants and 5 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
8-K 2.02,9.01
10-Q
8-K 2.02,9.01
8-K 5.07
SCHEDULE 13G —
SCHEDULE 13G —
10-Q
8-K 2.02,9.01
DEF 14A
DEFA14A
SCHEDULE 13G/A —
10-K
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.